Effects of HIV and antiretroviral therapy on resting energy expenditure in adult HIV-infected women-A matched, prospective, cross-sectional study

Journal of the Academy of Nutrition and Dietetics

Volumn 113, Issue 8, 2013, Pages 1037-1043

  Mittelsteadt, Alison L ^a   Hileman, Corrilynn O ^b   Harris, Stephanie R ^c   Payne, Kelly M ^c   Gripshover, Barbara M ^c,d   McComsey, Grace A ^b  

^a Department of Infectious Diseases ^*  (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Antiretroviral therapy; Human immunodeficiency virus (HIV); Resting energy expenditure (REE); Women

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT;

ADULT; ANTIRETROVIRAL THERAPY; ARTICLE; BASAL METABOLIC RATE; BODY COMPOSITION; BODY MASS; CALORIMETRY; CASE CONTROL STUDY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS (HIV); HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMPEDANCE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RESTING ENERGY EXPENDITURE (REE); VIRUS LOAD;

ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS (HIV); RESTING ENERGY EXPENDITURE (REE); WOMEN;

ADULT; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; BASAL METABOLISM; BODY COMPOSITION; BODY MASS INDEX; CALORIMETRY, INDIRECT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ELECTRIC IMPEDANCE; FEMALE; HIV INFECTIONS; HUMANS; PROSPECTIVE STUDIES; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84880700464     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2013.02.005     Document Type: Article

References (31)

1. Prejean J., Song R., Hernandez A., et al. Estimated HIV incidence in the United States, 2006-2009. PLoS ONE 2011, 6(8):e17502.
2. Hommes M.J., Romijn J.A., Endert E., Sauerwein H.P. Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic state. Am J Clin Nutr 1991, 54(2):311-315.
3. Grunfeld C., Pang M., Shimizu L., et al. Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1992, 55(2):455-460.
4. Slusarczyk R. The influence of the human immunodeficiency virus on resting energy expenditure. J Acquir Immune Defic Syndr 1994, 7(10):1025-1027.
5. Macallan D.C., Noble C., Baldwin C., et al. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995, 333(2):83-88.
6. Mulligan K., Tai V.W., Schambelan M. Energy expenditure in human immunodeficiency virus infection. N Engl J Med 1997, 336(1):70-71.
7. Sharpstone D., Ross H., Hancock M., et al. Indirect calorimetry, body composition and small bowel function in asymptomatic HIV-seropositive women. Int J STD AIDS 1997, 8(11):700-703.
8. Grinspoon S., Corcoran C., Miller K., et al. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab 1997, 82(5):1332-1337.
9. Grinspoon S., Corcoran C., Miller K., et al. Determinants of increased energy expenditure in HIV-infected women. Am J Clin Nutr 1998, 68(3):720-725.
10. Lane B.J., Provost-Craig M.A. Resting energy expenditure in asymptomatic HIV-infected females. J Womens Health Gend Based Med 2000, 9(3):321-327.
11. Grinspoon S., Corcoran C., Miller K., et al. Determinants of increased energy expenditure in HIV-infected women. Am J Clin Nutr 1998, 68(3):720-725.
12. Fitch K.V., Guggina L.M., Keough H.M., et al. Decreased respiratory quotient in relation to resting energy expenditure in HIV-infected and noninfected subjects. Metabolism 2009, 58(5):608-615.
13. Kotler D.P., Burastero S., Wang J., et al. Prediction of body cell mass, fat-free mas, and total body water with bioelectrical impedance analysis: Effects of race, sex, and disease. Am J Clin Nutr 1996, 64(3 suppl). 498S-497S.
14. Weir J.B. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 1949, 109(1-2):1-9.
15. Melchior J.C., Raguin G., Boulier A., et al. Resting energy expenditure in human immunodeficiency virus-infected patients: Comparison between patients with and without secondary infections. Am J Clin Nutr 1993, 57(5):614-619.
16. Sutinen J., Yki-Järvinen H. Increased resting energy expenditure, fat oxidation, and food intake in patients with highly active antiretroviral therapy-associated lipodystrophy. Am J Physiol Endocrinol Metab 2007, 292(3):E687-E692.
17. Kosmiski L.A., Kuritzkes D.R., Lichtenstein K.A., et al. Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome. AIDS 2001, 15(15):1993-2000.
18. van der Valk M., Reiss P., van Leth F.C., et al. Highly active antiretroviral therapy-induced lipodystrophy has minor effects on human immunodeficiency virus-induced changes in lipolysis, but normalizes resting energy expenditure. J Clin Endocrinol Metab 2002, 87(11):5066-5071.
19. Kosmiski L.A., Ringham B.M., Grunwald G.K., et al. Dual-energy x-ray absorptiometry modeling to explain the increased resting energy expenditure associated with the HIV lipoatrophy syndrome. Am J Clin Nutr 2009, 90:1525-1531.
20. Harman D. Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956, 11:298-300.
21. Sohal R.S., Orr W.C. The redox stress hypothesis of aging. Free Radic Biol Med 2012, 52(3):539-555.
22. Balaban R.S., Nemoto S., Finkel T. Mitochondria, oxidants and aging. Cell 2005, 120:483-495.
23. Kowaltowski A.J., Vercesi A.E. Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 1998, 26:463-471.
24. Wickens A.P. Ageing and the free radical theory. Respir Physiol 2001, 128:379-391.
25. McComsey G.A., Morrow J.D. Lipid oxidative markers are significantly increased in lipoatrophy, but not in sustained asymptomatic hyperlactemia. J Acquir Immune Defic Syndr 2003, 34:45-49.
26. Jumpertz R., Hanson R.L., Sievers M.L., et al. Higher energy expenditure in humans predicts natural morality. J Clin Endocrin Metab 2011, 96(6):E1-E5.
27. Ruggiero C., Metter E.J., Melenovsky V., et al. High basal metabolic rate is a risk factor for mortality: The Baltimore longitudinal study of aging. J Gerontology 2008, 63A(7):698-706.
28. Heilbronn L.K., de Jonge L., Frisard M.I., et al. Effect of 6-mo. calorie restriction on biomarkers of longevity, metabolic adaptation and oxidative stress in overweight subjects. JAMA 2006, 295(13):1539-1548.
29. Batterham M., Gold J., Naidoo D., et al. A preliminary open label dose comparison using an antioxidant regimen to determine the effect on viral load and oxidative stress in men with HIV/AIDS. Eur J Clin Nutr 2001, 55(2):107-114.
30. Compher C., Frankenfield D., Keim N., et al. Best practice methods to apply to measurement of resting metabolic rate in adults: A systematic review. J Am Diet Assoc 2006, 106:881-903.
31. White C.P., Hitchcock C.L., Vigna Y.M., et al. Fluid retention over the menstrual cycle: 1-year data from the prospective ovulation cohort [published online ahead of print August 8, 2011]. Obstet Gynecol Int 2011, 138451.